Pharmaco - Press Releases

Date	Title	Company
16-Mar-2022	Invitation to Cosmo’s full-year 2021 results and 2022 outlook webcast presentation on 23 March 2022	Cosmo Pharmaceuticals N.V.
16-Mar-2022	Kuros Biosciences reports results for the full year 2021	Kuros Biosciences AG
16-Mar-2022	SYNLAB AG: SYNLAB achieves record results in 2021 and exceeds all targets set at the IPO	SYNLAB AG
15-Mar-2022	National Comprehensive Cancer Network(R) Updates Designation of Monjuvi(R) (tafasitamab-cxix) to Preferred Regimen in its Clinical Practice Guidelines in Oncology for B-cell Lymphomas	MorphoSys AG
15-Mar-2022	Novasep invests €5.1 million in Le Mans to further expand its production capacity for HPAPIs	Novasep
15-Mar-2022	Animal health company Emollivet raises capital and strengthens team	Emollivet
15-Mar-2022	Santhera and ReveraGen to Present Efficacy and Safety Data with Vamorolone at 2022 Muscular Dystrophy Association Conference	Santhera Pharmaceuticals
15-Mar-2022	Almirall announces a collaboration with the University of Michigan to gain understanding of disease drivers in hidradenitis suppurativa	Almirall
15-Mar-2022	BioMed X Institute and Merck KGaA, Darmstadt, Germany, Start Second Research Project in Immunology	BioMed X
15-Mar-2022	Biocomposites to present data on STIMULAN® at American Academy of Orthopaedic Surgeons Annual Meeting	Biocomposites
15-Mar-2022	2022 PM Society Awards – Winners Announced	PM Society
15-Mar-2022	BioInnovation Institute announces latest cohort of companies entering Venture Lab program	BioInnovation Institute (BII)
15-Mar-2022	Gadeta announces significant progress in advancing pipeline and TEG platform development	Gadeta B.V.
15-Mar-2022	Sanofi announces €300 million collaboration with Blackstone Life Sciences to advance an innovative treatment for multiple myeloma	Sanofi
15-Mar-2022	APPLYING FUNDAMENTAL CONCEPTS OF ANTIMICROBIAL STEWARDSHIP IN ERA OF COVID-19	Accelerate Diagnostics, Inc.
15-Mar-2022	Moderna Announces First Participant Dosed In Phase 1 Study Of Its HIV Trimer mRNA Vaccine	Moderna
15-Mar-2022	F-star Therapeutics Reports Full-Year 2021 Financial Results and Provides Corporate Update	F-star Therapeutics
15-Mar-2022	Dante Labs unveils Dante Genomics, the Company’s B2B global online marketplace delivering genomic solutions for medical professionals, researchers and pharma	Dante Labs
15-Mar-2022	Adrenomed Supervisory Board appoints Dr. Richard Jones as CEO	Adrenomed AG
15-Mar-2022	BioMed X Institute and Merck KGaA, Darmstadt, Germany, Start Second Research Project in Immunology	B3C newswire